GLIVEC
Traitement des patients adultes et pédiatriques atteints de leucémie myéloïde chronique Ph+ (LMC Ph+) en …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
calcipotriolum
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
calcipotriolum monohydricum
|
- | Substance | WIZUS |
|
betamethasonum
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
betamethasoni dipropionas
|
- | Substance | WIZUS |
|
paraffinum liquidum
|
- | Substance | HNIDK |
|
polyoxypropyleni 11 aether stearylicus
|
- | Substance | HNIDK |
|
E 307
|
- | Substance | HNIDK |
|
E 321
|
0.05 MG | Substance | HBESI |
|
vaselinum album
|
- | Substance | HNIDK |
8302 Kloten